Full Press Release Details
Prestige Brands Announces Agreement to Acquire DenTek Holdings,
Acquisition Will Add Scale Brand and Expands Oral Care Platform
Conference Call Scheduled Today at 10:30am
Tarrytown, NY-November 23, 2015-Prestige Brands
Holdings, Inc. (NYSE-PBH) ("Prestige") today announced that it has entered into a definitive agreement to acquire DenTek
Oral Care, Inc. ("DenTek"), a privately-held marketer and distributor of oral care products for $225 million in cash.
This transaction would add pro forma revenues and adjusted EBITDA of approximately $60 million and $23 million, respectively on
an annualized basis.
The acquisition of DenTek will expand Prestige's
portfolio of iconic OTC brands into the fast-growing specialty oral care products category in the U.S., Australia and Europe. The
DenTek brand includes the #1 dental floss pick, as well as other oral care products for adults and children.
The Company plans to finance the acquisition with a combination
of funds from its existing credit facilities and available cash, and expects the transaction would add approximately a half point
to its leverage calculation at the time of the close. The transaction is expected to close during the first half of calendar year
2016, subject to customary closing conditions, including clearance under the Hart-Scott Rodino Antitrust Improvements Act of 1976.
"The acquisition of DenTek, when combined with our existing
oral care products, will create our fifth $100 million platform and provide the opportunity to enter the fast-growing specialty
oral care category anchored by the DenTek brand," said Ron Lombardi, President and CEO. "DenTek is an excellent fit
with our acquisition criteria, which is focused on using M&A to build our portfolio and create brand-building and innovation
opportunities for long-term growth. The DenTek brand complements our existing oral care platform and fits our business model with
outsourced manufacturing and distribution, allowing us to focus on our core competencies in marketing and sales," he said.
Mr. Lombardi continued, "The acquisition of DenTek will
mark our seventh transaction in the past six years as we continue to execute our proven strategy of acquiring, integrating and
building brands to grow our portfolio and increase shareholder value. This acquisition will bring our portfolio closer to our stated
objective of 85% invest for growth' brands and 15% manage for cash.' We look forward to adding the DenTek
brand to our growing portfolio and anticipate closing on this transaction during the first half of calendar year 2016, subject
to regulatory approvals."
Conference Call and Presentation
The Company will host a conference call today at 10:30 a.m.
ET to review the pending acquisition. The call may be accessed by dialing 877-784-9650 about 10 minutes before the start of the
call. International callers may dial 530-379-4717. A replay will be available for two weeks following the completion of the call
and can be accessed by dialing 855-859-2056 or 404-537-3406 for international. A slide presentation will accompany the call and
can be accessed from the Investors section of the Company's website, www.prestigebrands.com.
Non-GAAP Financial Measures
Pro forma adjusted EBITDA is a non-GAAP financial measure arrived
at by taking pro forma net income of $1.0 million and adding back depreciation and amortization of $2.0 million, interest expense
of $12.5 million, taxes of $0.5 million, and $7.0 million of transition, integration and purchase accounting to arrive at $23.0
About Prestige Brands Holdings, Inc.
The Company markets and distributes brand name over-the-counter
healthcare and household cleaning products throughout the U.S., Canada, and Australia and in certain other international markets.
Core brands include Monistat women's health products, Nix lice treatment, Chloraseptic sore throat treatments,
Clear Eyes eye care products, Compound W wart treatments, The Doctor's NightGuard dental protector, Little
Remedies pediatric products, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness
treatment, BC and Goody's pain relievers, Debrox earwax remover, and Gaviscon antacid in Canada. Visit the
Company's website at www.prestigebrands.com.
Note Regarding Forward-Looking Statements
This news release contains "forward-looking statements"
within the meaning of the federal securities laws that are intended to qualify for the Safe Harbor from liability established by
the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the
use of forward-looking terminology such as "will," "would," "expect," "plan," "continue,"
"anticipate" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking
statements" include, without limitation, statements regarding the expected timing for consummating the acquisition, the acquisition's
impact on revenues, adjusted EBITDA, leverage and shareholder value, the impact of the acquisition on the Company's portfolio
of brands and growth, the Company's expected financing, the rate of growth of the specialty oral care category, and the success
of the Company's strategy of acquiring, integrating and building brands. These statements are based on management's estimates
and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently
uncertain and difficult to predict. Actual results could differ materially from those in the forward-looking statements as a result
of a variety of factors, including satisfaction of the closing conditions, including approval under the Hart-Scott Rodino Antitrust
Improvements Act, general economic and business conditions, our ability to successfully integrate the DenTek brands and supply
chain, regulatory matters, competitive pressures, unexpected costs, or liabilities and disruptions resulting from the integration.
A discussion of other factors that could cause results to vary is included in the Company's Annual Report on Form 10-K for the
year ended March 31, 2015 and in Part II, Item 1A. Risk Factors in the Company's Quarterly Report on Form 10-Q for the quarter
ended September 30, 2015. Except to the extent required by applicable securities laws, we are not under any obligation to (and
expressly disclaim any such obligation to) update any forward-looking statements, whether as a result of new information, future
events, or otherwise. All statements contained in this press release are made only as of the date of this release.
Contact: Dean Siegal